Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Olanzapine soon to be hit by generic competition

    • 9 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Olanzapine soon to be hit by generic competition. Pharmacoecon. Outcomes News 472, 14 (2005). https://doi.org/10.2165/00151234-200504720-00041

    Download citation


    • Public Health
    • Health Outcome
    • Market Share
    • Risperidone
    • Olanzapine